Longboard Pharmaceuticals Stock Buy Hold or Sell Recommendation
| LBPH Stock | USD 59.80 0.03 0.05% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Longboard Pharmaceuticals is 'Strong Hold'. The recommendation algorithm takes into account all of Longboard Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Longboard Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide. In addition, we conduct extensive research on individual companies such as Longboard and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Longboard Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Longboard |
Execute Longboard Pharmaceuticals Buy or Sell Advice
The Longboard recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Longboard Pharmaceuticals. Macroaxis does not own or have any residual interests in Longboard Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Longboard Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Longboard Pharmaceuticals Trading Alerts and Improvement Suggestions
| Longboard Pharmaceuticals is way too risky over 90 days horizon | |
| Longboard Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Longboard Pharmaceuticals currently holds about 87.42 M in cash with (50.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09. | |
| Longboard Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Acquisition by Sekhri Paul J of 12500 shares of Longboard Pharmaceuticals at 7.06 subject to Rule 16b-3 |
Longboard Pharmaceuticals Returns Distribution Density
The distribution of Longboard Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Longboard Pharmaceuticals' future price movements. The chart of the probability distribution of Longboard Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Longboard Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Longboard Pharmaceuticals returns is essential to provide solid investment advice for Longboard Pharmaceuticals.
| Mean Return | 1.04 | Value At Risk | -5.74 | Potential Upside | 11.28 | Standard Deviation | 7.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Longboard Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Longboard Stock Institutional Investors
| Shares | Pictet Asset Manangement Sa | 2024-06-30 | 913.8 K | State Street Corp | 2024-06-30 | 801.9 K | Geode Capital Management, Llc | 2024-09-30 | 746.1 K | Parkman Healthcare Partners Llc | 2024-06-30 | 694.2 K | Emerald Advisers, Llc | 2024-09-30 | 683.6 K | Lord, Abbett & Co Llc | 2024-09-30 | 626.9 K | Jpmorgan Chase & Co | 2024-06-30 | 606.6 K | American Century Companies Inc | 2024-09-30 | 569.7 K | Driehaus Capital Management Llc | 2024-06-30 | 488.8 K | Fmr Inc | 2024-09-30 | 4.4 M | Farallon Capital Management, L.l.c. | 2024-09-30 | 3.2 M |
Longboard Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Longboard Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Longboard Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Longboard stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.86 | |
β | Beta against Dow Jones | 1.42 | |
σ | Overall volatility | 7.56 | |
Ir | Information ratio | 0.12 |
Longboard Pharmaceuticals Volatility Alert
Longboard Pharmaceuticals is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Longboard Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Longboard Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Longboard Pharmaceuticals Fundamentals Vs Peers
Comparing Longboard Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Longboard Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Longboard Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Longboard Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Longboard Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Longboard Pharmaceuticals to competition |
| Fundamentals | Longboard Pharmaceuticals | Peer Average |
| Return On Equity | -0.47 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Current Valuation | 2.05 B | 16.62 B |
| Shares Outstanding | 34.44 M | 571.82 M |
| Shares Owned By Insiders | 1.19 % | 10.09 % |
| Shares Owned By Institutions | 98.81 % | 39.21 % |
| Number Of Shares Shorted | 1.92 M | 4.71 M |
| Price To Book | 8.48 X | 9.51 X |
| EBITDA | (56.75 M) | 3.9 B |
| Net Income | (54.42 M) | 570.98 M |
| Cash And Equivalents | 87.42 M | 2.7 B |
| Cash Per Share | 5.09 X | 5.01 X |
| Total Debt | 475 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 11.95 X | 2.16 X |
| Book Value Per Share | 7.05 X | 1.93 K |
| Cash Flow From Operations | (50.87 M) | 971.22 M |
| Short Ratio | 0.58 X | 4.00 X |
| Earnings Per Share | (2.25) X | 3.12 X |
| Target Price | 64.67 | |
| Number Of Employees | 50 | 18.84 K |
| Beta | 1.09 | -0.15 |
| Market Capitalization | 2.33 B | 19.03 B |
| Total Asset | 50.7 M | 29.47 B |
| Retained Earnings | (140.56 M) | 9.33 B |
| Working Capital | 40.45 M | 1.48 B |
| Net Asset | 50.7 M |
Note: Acquisition by Kaye Randall of 30554 shares of Longboard Pharmaceuticals at 6.0 subject to Rule 16b-3 [view details]
Longboard Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Longboard . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Longboard Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Longboard Pharmaceuticals? Buying financial instruments such as Longboard Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Longboard Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Longboard Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.25) | Return On Assets (0.31) | Return On Equity (0.47) |
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.